Moderna, Inc.
MRNA
$51.38
-$0.99-1.89%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/16/2026
-
MarketBeat
3/21/2026
-
MarketBeat
3/21/2026
-
The Motley Fool UK
3/20/2026
-
Zacks Investment Research
3/20/2026
-
Zacks Investment Research
3/20/2026
-
Stock Options Channel
3/20/2026
-
MarketBeat
3/20/2026
-
Zacks Investment Research
3/20/2026
-
Zacks Investment Research
3/20/2026
-
Zacks Investment Research
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
3/20/2026
-
StockStory Articles
3/20/2026
-
StockStory Articles
3/19/2026
-
Nasdaq News: Markets
3/19/2026
-
Fool.com Headlines
3/19/2026
-
MarketBeat
3/19/2026
-
Zacks Investment Research
3/19/2026
-
Tickeron - Technical Analysis
3/18/2026
-
TipRanks Financial Blog
3/18/2026
-
MarketBeat
3/18/2026
-
StockStory Articles
3/17/2026
-
MarketBeat
3/17/2026
-
MarketBeat
3/17/2026
-
FiercePharma
3/17/2026
-
Zacks Investment Research
1/29/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 20, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 714 6500
Address
325 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mNEXSPIKE...
more